D-0572-2026 Class II Ongoing

Recalled by Guardian Drug Co. Inc. — Dayton, NJ

FDA drug recall D-0572-2026 was initiated by Guardian Drug Co. Inc. on May 28, 2026 and is designated Class II. Reason for recall: Presence of foreign substance: small metallic particles in chewable tablets. The recall status is ongoing.

Recall Details

Product Type
Drugs
Report Date
June 10, 2026
Initiation Date
May 28, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

HyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS, DISTRIBUTED BY: HY-VEE INC., Inc., WEST DES MOINES, IA 50266, UPC: 0 75450 82514 5.

Reason for Recall

Presence of foreign substance: small metallic particles in chewable tablets.

Distribution Pattern

U.S.A. Nationwide

Code Information

Lot #: 1716089, expires: JAN 2029.